Data gathered: November 8
Alternative Data for Jazz Pharmaceuticals
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 71 | Sign up | Sign up | Sign up |
| Sentiment | 94 | Sign up | Sign up | Sign up |
| Webpage traffic | 123,000 | Sign up | Sign up | Sign up |
| Employee Rating | 64 | Sign up | Sign up | Sign up |
| Google Trends | 48 | Sign up | Sign up | Sign up |
| Patents | 88 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 3,972 | Sign up | Sign up | Sign up |
| Twitter Followers | 3,565 | Sign up | Sign up | Sign up |
| Twitter Mentions | 20 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | 64 | Sign up | Sign up | Sign up |
| Business Outlook | 42 | Sign up | Sign up | Sign up |
| Linkedin Employees | 3,386 | Sign up | Sign up | Sign up |
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for unmet medical needs in the United States, Europe, and internationally.
| Price | $121.95 |
| Target Price | Sign up |
| Volume | 153,930 |
| Market Cap | $6.89B |
| Year Range | $100.57 - $125 |
| Dividend Yield | 0% |
| PE Ratio | 18.94 |
| Analyst Rating | 83% buy |
| Industry | Biotechnology |
In the news
 |
Robeco Institutional Asset Management B.V. Sells 19,161 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)November 7 - ETF Daily News |
Jazz Pharmaceuticals : UK Holdings Limited 4.6% Fixed Rate Note due 15 January 2029 2024 Financials Interim ReportNovember 6 - Finnhub |
|
Jazz Pharmaceuticals : UK Holdings Limited 4.6% Fixed Rate Note due 15 January 2029 2024 Financial Results Q3November 6 - Finnhub |
|
 |
Jazz Pharmaceuticals PLC (JAZZ) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...November 6 - Yahoo |
 |
Jazz Pharmaceuticals Announces Third Quarter 2024 Financial ResultsNovember 6 - PR Newswire UK |
 |
Compared to Estimates, Jazz (JAZZ) Q3 Earnings: A Look at Key MetricsNovember 6 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '24 | 1.02B | 494M | 531M | 169M | 355M | 5.300 |
| Q1 '24 | 900M | 507M | 393M | -15M | 222M | 2.680 |
| Q4 '23 | 988M | 548M | 440M | 94M | 275M | 5.020 |
| Q3 '23 | 971M | 463M | 508M | 147M | 327M | 4.840 |
| Q2 '23 | 955M | 493M | 462M | 104M | 310M | 4.510 |
Insider Transactions View All
| Henderson Mary Elizabeth filed to sell 14,531 shares at $108.3. September 11 '24 |
| Carr Patricia filed to sell 6,596 shares at $108.8. June 11 '24 |
| Patil Neena M filed to sell 36,629 shares at $109.7. May 7 '24 |
| Carr Patricia filed to sell 6,596 shares at $117. March 8 '24 |
| Carr Patricia filed to sell 8,364 shares at $117.5. March 8 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Daniel S. Goldman Democrat |
Aug 13, 23 | Sell | $15K - $50K |
| Rohit Khanna Democrat |
Jun 12, 23 | Sell | $1K - $15K |
| Daniel S. Goldman Democrat |
Apr 17, 23 | Buy | $15K - $50K |
Read more about Jazz Pharmaceuticals (JAZZ) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Jazz Pharmaceuticals?
The Market Cap of Jazz Pharmaceuticals is $6.89B.
What is Jazz Pharmaceuticals' PE Ratio?
As of today, Jazz Pharmaceuticals' PE (Price to Earnings) ratio is 18.94.
What is the current stock price of Jazz Pharmaceuticals?
Currently, the price of one share of Jazz Pharmaceuticals stock is $121.95.
How can I analyze the JAZZ stock price chart for investment decisions?
The JAZZ stock price chart above provides a comprehensive visual representation of Jazz Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Jazz Pharmaceuticals shares. Our platform offers an up-to-date JAZZ stock price chart, along with technical data analysis and alternative data insights.
Does JAZZ offer dividends to its shareholders?
As of our latest update, Jazz Pharmaceuticals (JAZZ) does not offer dividends to its shareholders. Investors interested in Jazz Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Jazz Pharmaceuticals?
Some of the similar stocks of Jazz Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.